817 results on '"Frustaci, Andrea"'
Search Results
2. COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review
3. Prevalence and Clinical Implications of COVID-19 Myocarditis
4. Novel ATP2A2 Gene Mutation c.118G>A Causing Keratinocyte and Cardiomyocyte Disconnection in Darier Disease
5. Long‐Term Clinical‐Pathologic Results of Enzyme Replacement Therapy in Prehypertrophic Fabry Disease Cardiomyopathy
6. Endomyocardial Biopsy
7. Immunosuppressive Therapy in Myocarditis: Lessons from Clinical Trials and Future Perspectives
8. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
9. Abstract 10450: Interleukin-17A-Correlated Myocarditis in Patients With Psoriasis
10. Use of the new Lake Louise Criteria improves CMR detection of atypical forms of acute myocarditis
11. Cardiomyocyte Regeneration in Human Myocarditis.
12. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.
13. Immunomodulating and Immunosuppressive Therapy for Virus-Negative Immune-Mediated Myocarditis.
14. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation
15. Cardiomyocyte Regeneration in Human Myocarditis
16. Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
17. Primary aldosteronism-associated cardiomyopathy: Clinical-pathologic impact of aldosterone normalization
18. Hypersensitivity Myocarditis Following Deferasirox Administration
19. Infertility in Fabry's Disease: role of hypoxia and inflammation in determining testicular damage.
20. Fabry Cardiomyopathy: Myocardial Fibrosis, Inflammation and Down-Regulation of Mannose6Phosphate Receptors cause Low accessibility to Enzyme Replacement Therapy
21. Pathogenic contribute of unaffected cardiac cells in female Fabry cardiomyopathy
22. Novel Genetic Microvascular Dysplasia Causing Hypoperfusion of Cardiac, Renal, and Cerebral Circulation
23. Novel Genetic Systemic Obstructive Microvascular Dysplasia
24. Surface Roughness of Commercial Composites after Different Polishing Protocols: An Analysis with Atomic Force Microscopy
25. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
26. Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy
27. The inflammatory spectrum of cardiomyopathies.
28. Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series
29. Undiagnosed Fabry disease: the importance of screening for Fabry disease before transcutaneous patent foramen ovale closure in a young patient with cryptogenic stroke
30. Kappa-light Chain Amyloid Overlapping Hypertrophic Cardiomyopathy With Myocardial Noncompaction
31. Circulating Anti-GB3 Antibody as a Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy
32. Interleukin 17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery Following Secukinumab Administration
33. Circulating Anti-GB3 Antibody as Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy
34. Histological and proteomic profile of diabetic versus non-diabetic dilated cardiomyopathy
35. Arrhythmic Phenotype of Myocarditis Sustained by a Prominent Infiltration of Conduction Tissue
36. Hypersensitivity Myocarditis and Necrotizing Coronary Vasculitis by Clomipramine Causing Steroid-Sensitive Cardiogenic Shock
37. Infiltration of Conduction Tissue Is a Major Cause of Electrical Instability in Cardiac Amyloidosis
38. Prednisone administration in inflammatory cardiomyopathy: caveat for potentially adverse myocardial actions
39. Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy
40. Remarks on Myocarditis Associated with COVID-19 Infection and Myocarditis Following mRNA COVID-19 Vaccination
41. Individualized immunosuppression in virus-negative inflammatory cardiomyopathy
42. Myocarditis followingCOVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
43. Delphi consensus on the current clinical and therapeutic knowledge on Anderson–Fabry disease
44. Immunosuppressive treatment of inflammatory cardiomyopathy patients
45. Strengths and Limitations of the Evidence-Based Movement Aimed to Improve Clinical Outcomes in Dentistry and Oral Surgery
46. CMR Sensitivity Varies With Clinical Presentation and Extent of Cell Necrosis in Biopsy-Proven Acute Myocarditis
47. A rare case report of hypertrophic cardiomyopathy induced by catecholamine-producing tumor
48. Auto-Reactive Myocarditis and Necrotizing Coronary Vasculitis After Blunt Chest Trauma
49. Transitory ventricular tachycardia associated with influenza A infection of cardiac conduction tissue
50. Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.